[ij] [ij] [ij] 
Email id

Asian Journal of Pharmaceutical Analysis
Year : 2019, Volume : 9, Issue : 4
First page : ( 224) Last page : ( 228)
Print ISSN : 2231-5667. Online ISSN : 2231-5675.
Article DOI : 10.5958/2231-5675.2019.00038.3

Simultaneous Estimation of Candesartan and Hydrochlorothiazide in Combined Tablet Dosage Form by RP-HPLC

Pappula Nagaraju*, Ravichandra S., Sindhura S. Lakshmi, Rani P. Asha, Madhuri V. Seshu, Ajay V., Reddy P. Narsi

Department of Pharmaceutical Analysis, Hindu College of Pharmacy, Amravathi Road, Guntur-522002, Andhra Pradesh, India

*Corresponding Author E-mail: pappulanagaraju@gmail.com

Online published on 31 December, 2019.


The study describes method development and subsequent validation of RP-HPLC method for simultaneous estimation of candesartan and hydrochlorothiazide in combined tablet dosage forms. Chromatographic separation was achieved on a Hypersil BDS C8 column (250 mm x 4.6 mm, 5 μm) using a mobile phase consisting of (40: 60 v/v) acetonitrile: triethylamine (0.02%) at a flow rate of 1 mL/min. The detection wavelength is 262 nm. The retention times of candesartan and hydrochlorothiazidewere found to be 2.449 min and 4.895 min respectively. The developed method was validated as per ICH guidelines. The developed and validated method was successfully used for the quantitative analysis of candesartan and hydrochlorothiazidein tablet dosage forms.



RP-HPLC method, Candesartan, Hydrochlorothiazide, Validation.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
741,433,407 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.